Disa India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 1:18 pm

Quick Insight

Disa India Ltd, operating in the heavy engineering industry, currently trades at a price of 13,636 with a market cap of 1,983 Cr. The company's P/E ratio stands at 38.0, indicating a relatively high valuation, while boasting a solid ROE of 21.2% and ROCE of 28.9%. With an OPM of 15% and a net profit of 50 Cr, Disa India Ltd seems to be efficiently managing its operations. The company's strong ICR of 155.78x reflects a healthy financial position, supported by reserves of 265 Cr and minimal borrowings of ₹1Cr. However, the high P/BV ratio of 7.57x suggests a premium valuation. Investors should closely monitor the company's CCC of 73 days for any potential working capital concerns.

Competitors of Disa India Ltd

All Competitor Stocks of Disa India Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:00 pm

Below is a detailed analysis of the quarterly data for Disa India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 102.00 Cr.. The value appears to be declining and may need further review. It has decreased from 108.00 Cr. (Mar 2025) to 102.00 Cr., marking a decrease of 6.00 Cr..
• For Expenses, as of Jun 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 90.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Mar 2025) to 15.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Mar 2025) to 26.00%, marking a decrease of 3.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 89.67. The value appears strong and on an upward trend. It has increased from 87.47 (Mar 2025) to 89.67, marking an increase of 2.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:47 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:25 pm

Below is a detailed analysis of the balance sheet data for Disa India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 265.00 Cr.. The value appears strong and on an upward trend. It has increased from 244.00 Cr. (Mar 2024) to 265.00 Cr., marking an increase of 21.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 169.00 Cr.. The value appears to be improving (decreasing). It has decreased from 172.00 Cr. (Mar 2024) to 169.00 Cr., marking a decrease of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 420.00 Cr. (Mar 2024) to 437.00 Cr., marking an increase of 17.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2024) to 61.00 Cr., marking an increase of 15.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 375.00 Cr.. The value appears strong and on an upward trend. It has increased from 373.00 Cr. (Mar 2024) to 375.00 Cr., marking an increase of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 437.00 Cr.. The value appears strong and on an upward trend. It has increased from 420.00 Cr. (Mar 2024) to 437.00 Cr., marking an increase of 17.00 Cr..

Notably, the Reserves (265.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Disa India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 346.72. This value is within the healthy range. It has increased from 294.87 (Mar 24) to 346.72, marking an increase of 51.85.
• For Diluted EPS (Rs.), as of Mar 25, the value is 346.72. This value is within the healthy range. It has increased from 294.87 (Mar 24) to 346.72, marking an increase of 51.85.
• For Cash EPS (Rs.), as of Mar 25, the value is 380.83. This value is within the healthy range. It has increased from 328.41 (Mar 24) to 380.83, marking an increase of 52.42.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,838.96. It has increased from 1,695.93 (Mar 24) to 1,838.96, marking an increase of 143.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,838.96. It has increased from 1,695.93 (Mar 24) to 1,838.96, marking an increase of 143.03.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,692.00. It has increased from 2,265.86 (Mar 24) to 2,692.00, marking an increase of 426.14.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 547.93. This value is within the healthy range. It has increased from 453.10 (Mar 24) to 547.93, marking an increase of 94.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is 514.83. This value is within the healthy range. It has increased from 420.41 (Mar 24) to 514.83, marking an increase of 94.42.
• For PBT / Share (Rs.), as of Mar 25, the value is 473.72. This value is within the healthy range. It has increased from 397.93 (Mar 24) to 473.72, marking an increase of 75.79.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 347.72. This value is within the healthy range. It has increased from 295.72 (Mar 24) to 347.72, marking an increase of 52.00.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 347.72. This value is within the healthy range. It has increased from 295.72 (Mar 24) to 347.72, marking an increase of 52.00.
• For PBDIT Margin (%), as of Mar 25, the value is 20.35. This value is within the healthy range. It has increased from 19.99 (Mar 24) to 20.35, marking an increase of 0.36.
• For PBIT Margin (%), as of Mar 25, the value is 19.12. This value is within the healthy range. It has increased from 18.55 (Mar 24) to 19.12, marking an increase of 0.57.
• For PBT Margin (%), as of Mar 25, the value is 17.59. This value is within the healthy range. It has increased from 17.56 (Mar 24) to 17.59, marking an increase of 0.03.
• For Net Profit Margin (%), as of Mar 25, the value is 12.91. This value exceeds the healthy maximum of 10. It has decreased from 13.05 (Mar 24) to 12.91, marking a decrease of 0.14.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.91. This value is within the healthy range. It has decreased from 13.05 (Mar 24) to 12.91, marking a decrease of 0.14.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.90. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 18.90, marking an increase of 1.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.78. This value is within the healthy range. It has decreased from 24.69 (Mar 24) to 21.78, marking a decrease of 2.91.
• For Return On Assets (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 10.21 (Mar 24) to 11.54, marking an increase of 1.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has increased from 0.84 (Mar 24) to 0.91, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 3.66. This value exceeds the healthy maximum of 3. It has increased from 2.11 (Mar 24) to 3.66, marking an increase of 1.55.
• For Quick Ratio (X), as of Mar 25, the value is 2.84. This value exceeds the healthy maximum of 2. It has increased from 1.62 (Mar 24) to 2.84, marking an increase of 1.22.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 4. It has decreased from 2.66 (Mar 24) to 2.45, marking a decrease of 0.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 37.29 (Mar 24) to 0.00, marking a decrease of 37.29.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 33.57 (Mar 24) to 0.00, marking a decrease of 33.57.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 62.71 (Mar 24) to 0.00, marking a decrease of 62.71.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 66.43 (Mar 24) to 0.00, marking a decrease of 66.43.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 155.78. This value is within the healthy range. It has increased from 92.54 (Mar 24) to 155.78, marking an increase of 63.24.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 110.55. This value is within the healthy range. It has increased from 64.99 (Mar 24) to 110.55, marking an increase of 45.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,809.00. It has increased from 1,774.28 (Mar 24) to 1,809.00, marking an increase of 34.72.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.63. This value exceeds the healthy maximum of 3. It has decreased from 5.40 (Mar 24) to 4.63, marking a decrease of 0.77.
• For EV / EBITDA (X), as of Mar 25, the value is 22.77. This value exceeds the healthy maximum of 15. It has decreased from 27.01 (Mar 24) to 22.77, marking a decrease of 4.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.17. This value exceeds the healthy maximum of 3. It has decreased from 6.11 (Mar 24) to 5.17, marking a decrease of 0.94.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 62.70 (Mar 24) to 0.00, marking a decrease of 62.70.
• For Price / BV (X), as of Mar 25, the value is 7.57. This value exceeds the healthy maximum of 3. It has decreased from 8.16 (Mar 24) to 7.57, marking a decrease of 0.59.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.17. This value exceeds the healthy maximum of 3. It has decreased from 6.11 (Mar 24) to 5.17, marking a decrease of 0.94.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness